Mader, Jamie S <br/><br/>
Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.  [electronic resource] 

 -  The American journal of pathology  Nov 2006 
 - 1753-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9440 
<br/><br/><label>Standard No.: </label>10.2353/ajpath.2006.051229  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Binding, Competitive--drug effects<br/>Cattle<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Collagen--drug effects<br/>Drug Combinations<br/>Endothelial Cells--cytology<br/>Fibroblast Growth Factor 2--pharmacology<br/>Heparin--metabolism<br/>Humans<br/>Lactoferrin--pharmacology<br/>Laminin--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Neovascularization, Physiologic--drug effects<br/>Protein Binding--drug effects<br/>Proteoglycans--drug effects<br/>Vascular Endothelial Growth Factor A--pharmacology